LEN vs MASS · rev $34.19B vs rev $59.6M
LEN (LEN) versus 908 Devices Inc (MASS) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
908 Devices Inc (MASS) is a medical devices company listed on US.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
Latest reported MASS revenue for 2024-12-31 was $59.6M. Net income was -$72.2M. Revenue was up 18.7% from 2023-12-31 to 2024-12-31. MASS currently screens at market cap $238.5M.
LEN currently screens at market cap $0. MASS currently screens at market cap $238.5M.
Not investment advice. Open the LEN and MASS stock pages for the full models.
Not investment advice.